{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:25:59Z","timestamp":1770071159641,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPQ","doi-asserted-by":"publisher","award":["474397\/2013-0"],"award-info":[{"award-number":["474397\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","award":["2297-2551\/14-0"],"award-info":[{"award-number":["2297-2551\/14-0"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hormones and Behavior"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.yhbeh.2015.05.018","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T06:15:31Z","timestamp":1435644931000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice"],"prefix":"10.1016","volume":"73","author":[{"given":"Michelle S.","family":"Antunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jossana Rodrigues","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieniffer","family":"de Oliveira Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela Bastos","family":"Piegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maicon Lenon Otenio","family":"de Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellen Atha\u00edde","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Gomes","family":"de Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Tiago Rossito","family":"Goes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Cattelan","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciele","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Peterini","family":"Boeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano R.","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yhbeh.2015.05.018_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.euroneuro.2012.01.008","article-title":"Hippocampus-specific deletion of tissue plasminogen activator \u201ctPA\u201d in the adult mice impairs depression- and anxiety-like behaviors","volume":"22","author":"Bahi","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-7-93","article-title":"Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide","volume":"7","author":"Corona","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbi.2012.08.008","article-title":"Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice","volume":"31","author":"Corona","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0030","first-page":"1","article-title":"ELISA. Theory and practice","volume":"42","author":"Crowther","year":"1995","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b2(1\u201340)) administration in mice","volume":"244","author":"Dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0040","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1471-4159.1991.tb06359.x","article-title":"Stress- and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity","volume":"57","author":"Dunn","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1073\/pnas.76.3.1145","article-title":"Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine","volume":"76","author":"Fujiwara","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbi.2012.11.010","article-title":"Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression","volume":"28","author":"Gibney","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0060","first-page":"1","article-title":"Brain-derived neurotrophic factor as a suicide factor in mental disorders","volume":"13","author":"Grah","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0070","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1460-9568.2003.02802.x","article-title":"Methylenedioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine","volume":"18","author":"Harkin","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.284.5.592","article-title":"Pituitary\u2013adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood","volume":"284","author":"Heim","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-8993(89)90101-7","article-title":"Systemic endotoxin increases l-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex","volume":"491","author":"Heyes","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0091-3057(94)90243-7","article-title":"Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain","volume":"49","author":"Inoue","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.euroneuro.2006.06.011","article-title":"Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression","volume":"17","author":"Jim\u00e9nez-Vasquez","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(01)00625-6","article-title":"Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test","volume":"71","author":"Kitamura","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: from animals to humans","volume":"47","author":"Kormos","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2007.01.002","article-title":"Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity","volume":"62","author":"Lang","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S1461145709991234","article-title":"Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression","volume":"13","author":"Laske","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pnpbp.2009.03.004","article-title":"Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system","volume":"33","author":"Machado","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/da.20540","article-title":"Treatment-resistant depression: recent developments and future directions","volume":"25","author":"Mathew","year":"2008","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/0033-2909.133.1.25","article-title":"If it goes up, must it come down? Chronic stress and the hypothalamic\u2013pituitary\u2013adrenocortical axis in humans","volume":"133","author":"Miller","year":"2007","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0140","first-page":"336","article-title":"The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions","volume":"1","author":"Nemeroff","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0150","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","article-title":"Induction of IDO by bacille Calmette\u2013Guerin is responsible for development of murine depressive-like behavior","volume":"182","author":"O'Connor","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.npep.2012.01.002","article-title":"Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity","volume":"46","author":"Olesen","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0160","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1176\/appi.ajp.159.3.419","article-title":"Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims","volume":"159","author":"Pandey","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0165","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2003"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0170","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0180","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0024-3205(01)01498-9","article-title":"Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus","volume":"70","author":"Rodrigues","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0185","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.peptides.2009.12.015","article-title":"Behavioral effects of neuropeptides in rodent models of depression and anxiety","volume":"31","author":"Rotzinger","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0190","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1523\/JNEUROSCI.0659-07.2008","article-title":"Neuropeptide Y in the amygdala induces long term resilience to stress-induced reductions in social responses but not hypothalamic\u2013adrenal\u2013pituitary axis activity or hyperthermia","volume":"28","author":"Sajdyk","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.yhbeh.2012.03.010","article-title":"Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge","volume":"62","author":"Salazar","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0200","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1586\/ern.09.52","article-title":"Hypothalamic\u2013pituitary\u2013adrenocortical system dysregulation and new treatment strategies in depression","volume":"9","author":"Schule","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0210","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s11064-010-0183-6","article-title":"Intranasal administration of nerve growth factor produces antidepressant-like effects in animals","volume":"35","author":"Shi","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0215","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0021-9258(18)94231-6","article-title":"The roles of superoxide anion and methylene blue in the reductive activation of indoleamine 2,3-dioxygenase by ascorbic acid or by xanthine oxidase\u2013hypoxanthine","volume":"264","author":"Sono","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0220","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.270.5236.593","article-title":"Neurotrophins and neuronal plasticity","volume":"270","author":"Thoenen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(03)03338-9","article-title":"Effects of different kinds of acute stress on nerve growth factor content in rat brain","volume":"987","author":"Von Richthofen","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.yhbeh.2015.05.018_bb0240","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","article-title":"The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters","volume":"31","author":"Zhu","year":"2006","journal-title":"Neuropsychopharmacology"}],"container-title":["Hormones and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0018506X15001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0018506X15001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T02:03:26Z","timestamp":1652666606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0018506X15001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":46,"alternative-id":["S0018506X15001099"],"URL":"https:\/\/doi.org\/10.1016\/j.yhbeh.2015.05.018","relation":{},"ISSN":["0018-506X"],"issn-type":[{"value":"0018-506X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice","name":"articletitle","label":"Article Title"},{"value":"Hormones and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yhbeh.2015.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}